Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo I Altieri

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Puerto Rico Health Sciences Journal|January 8, 2015
The mysterious HDLWilma González, Pablo I Altieri
Boletin De La Asociacion Medica De Puerto Rico|January 9, 2016
Obesity and premature coronary artery disease with myocardial infarction in Puerto Rican young adultsJosé M Marcial, Pablo I Altieri
Boletin De La Asociacion Medica De Puerto Rico|November 23, 2017
Inflammation, Obesity and the Metabolic Syndrome. Implications in HispanicsJosé Marcial, Pablo I Altieri, Héctor L Banchs
Vascular Pharmacology|March 1, 2006
Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamstersMaria J Crespo, Pablo I Altieri, Nelson Escobales
American Journal of Therapeutics|October 1, 1994
Dose-Related Hemodynamic Effects of Enalaprilat in Patients with Ischemic Heart DiseaseRobert A. González-Fernández, Pablo I. Altieri, Raúl Jiménez, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 15, 2010
Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamstersMaría J Crespo, Nildris Cruz, Pablo I Altieri, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2008
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamsterMaria J Crespo, Nildris Cruz, Pablo I Altieri, et al.
Journal of Cardiovascular Pharmacology|February 29, 2012
Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamstersMaria J Crespo, Jose L Cangiano, Pablo I Altieri, et al.
American Journal of Therapeutics|June 1, 1995
Effects of Enalaprilat on Regional Wall Stress in Patients with Angina PectorisRobert A. González-Fernández, Pablo I. Altieri, Hector L. Banchs, et al.
Boletin De La Asociacion Medica De Puerto Rico|November 29, 2013
Ethnicity and genetics are more important than diabetes mellitus and hypertension in producing cardiovascular events in patients with the metabolic syndrome: emphasis in the Puerto Rico populationPablo I Altieri, José M Marcial, Héctor Banchs, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Puerto Rico Health Sciences Journal|January 8, 2015
The mysterious HDLWilma González, Pablo I Altieri
Boletin De La Asociacion Medica De Puerto Rico|January 9, 2016
Obesity and premature coronary artery disease with myocardial infarction in Puerto Rican young adultsJosé M Marcial, Pablo I Altieri
Boletin De La Asociacion Medica De Puerto Rico|November 23, 2017
Inflammation, Obesity and the Metabolic Syndrome. Implications in HispanicsJosé Marcial, Pablo I Altieri, Héctor L Banchs
Vascular Pharmacology|March 1, 2006
Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamstersMaria J Crespo, Pablo I Altieri, Nelson Escobales
American Journal of Therapeutics|October 1, 1994
Dose-Related Hemodynamic Effects of Enalaprilat in Patients with Ischemic Heart DiseaseRobert A. González-Fernández, Pablo I. Altieri, Raúl Jiménez, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 15, 2010
Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamstersMaría J Crespo, Nildris Cruz, Pablo I Altieri, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2008
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamsterMaria J Crespo, Nildris Cruz, Pablo I Altieri, et al.
Journal of Cardiovascular Pharmacology|February 29, 2012
Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamstersMaria J Crespo, Jose L Cangiano, Pablo I Altieri, et al.
American Journal of Therapeutics|June 1, 1995
Effects of Enalaprilat on Regional Wall Stress in Patients with Angina PectorisRobert A. González-Fernández, Pablo I. Altieri, Hector L. Banchs, et al.
Boletin De La Asociacion Medica De Puerto Rico|November 29, 2013
Ethnicity and genetics are more important than diabetes mellitus and hypertension in producing cardiovascular events in patients with the metabolic syndrome: emphasis in the Puerto Rico populationPablo I Altieri, José M Marcial, Héctor Banchs, et al.
Pageof 3